Apply
Associate Prof of Pharmaceutics Chair, Dept of Pharmaceutics, Pharmacy Practice & Public Health

Omolo, Calvin, PhD., MPSK

Prof. (Dr.) Calvin Andeve Omolo is an Associate Professor of Pharmaceutics in the School of Pharmacy and Health Sciences. He was awarded a College of Health Sciences Scholarship for Masters and PhD at the University of KwaZulu-Natal in South Africa. His research focuses on the design and synthesis of biomaterials that are employed in the formulation and characterization of various novel medicines for various diseases. In the last 6 years his focus has specifically been the development of novel materials and antibiotic novel drug delivery systems (NDDS) to target disease sites. Based on his research publications outputs, he can be regarded as one of the emerging researchers in this area globally. He is competing with leading researchers internationally and focuses on emerging cutting-edge nanotechnology approaches for designing “intelligent” pharmaceutical materials and architectural designs of new generation NDDS for improving treatment of infectious diseases and overcoming antimicrobial resistance. His current h-index is calculated as 17 (Google Scholar) with almost 607 citations, including papers in Q1/Top 10 pharmaceutical sciences, medicine and bioengineering journals such as Advanced Functional Material (IF 18.808), Journal of Controlled Release (IF 11.467), International Journal of Biological Macromolecules (IF 8.025), International Journal of Pharmaceutics (IF 6.510), WIREs Nanomedicine & Nanobiotechnology (IF 9.423), Colloids And Surfaces B-Biointerfaces (5.999), Journal of Drug Delivery Science and Technology (IF 5.062), Pharmaceutics (IF 6.525), Molecular Pharmaceutics (IF 5.364) and others. He has 38 publications, 5 book chapters and 2 book credits in reputable ISI journals and Publishing houses and 20 local and international conference contributions. Prof. Omolo has secured several scholarships/research grants. He has successfully supervised several students at Masters, PhD and Postdoctoral levels, several passing with distinction and achieving international and national awards/appointments. Prof. Omolo’s main areas of teaching are Physical Pharmacy, which provides students with a physicochemical background in the formulation of dosage forms, and Pharmaceutical Technology, which provides knowledge and skills to manufacture and evaluate dosage forms. Pharmaceutical Microbiology equips the students with knowledge and understanding of pharmaceutical microbiology relevant to the healthcare and pharmaceutical industry, Pharmacy practice which entails teaching students the different fields of pharmacy where they can practice, and pharmaceutical management which equips the students with skills to handle and store different types of medications and excipients in their capacity as custodian of drugs. Prof. Omolo has achieved considerable international recognition as a scientist. These have included, invited reviewer of papers from several top ranking international journals (e.g. Journal of Controlled Release, Colloids and Surfaces, Nature), invited author to submit several review papers for top ranking journals (e.g. Journal of Controlled Release), invited author for a book chapter from global leader in drug delivery (Prof V Torchilin), invitations from international scientific bodies to review research proposals ( National Research Foundation of South Africa), invitations from several international universities to be a visiting scientist, an external examiner, and curriculum development and review both nationally and internationally. He has also established collaborations with leading universities internationally that have led to research grants and publications. He is currently a chair of Department for Pharmaceutics and Pharmacy Practice, Member on the USIU-Africa Institutional review Board. He is also a registered Pharmacist with the Pharmacy and Poison’s Board of Kenya and member of the American Association of Pharmaceutical Scientists (AAPS), and Academy of Pharmaceutical Sciences of South Africa and Pharmaceutical Society of Kenya.
Email Address

comolo@usiu.ac.ke

Location

Nairobi, Kenya

AREAS OF SPECIALIZATION

  • Biomaterials
  • Pharmaceutical microbiology
  • Novel drug delivery systems
  • Dosage form design
  • Nanomedicine
  • Polymer chemistry
  • Targeted drug delivery systems
  • GMP
  • Pharmaceutical quality control
  • Pharmacy Practice

ACADEMIC QUALIFICATIONS

  • Doctor of Philosophy (PhD) in Pharmaceutics – University of KwaZulu-Natal, Durban, South Africa (2019)
  • Master of Pharmacy (Summa Cum Laude) – University of KwaZulu-Natal, Durban, South Africa (2016)
  • Bachelor of Pharmacy – St John’s University of Tanzania (2013)

 

TEACHING

  • PHM 4416: Dispensing and Pharmacy Practice
  • PHM 5416: Dosage forms
  • PHM 5417: Pharmaceutical Microbiology

PUBLICATIONS

Journal Articles:

  1. Zhan, Y., Hu, X., Li, Y., Wang, Y., Chen, H., Omolo, C. A., … & Liu, Y. (2023). Antimicrobial Hybrid Amphiphile via Dynamic Covalent Bonds Enables Bacterial Biofilm Dispersal and Bacteria Eradication. Advanced Functional Materials, 2214299. (Impact factor 18.808).
  2. Nwabuife, J. C., Omolo, C. A., Abdallah, E. I., Gafar, M. A., Mohammed, M., Rambharose, S., & Govender, T. (2023). P04 Dual pH/enzyme-responsive capsules of ciprofloxacin; a strategy to maximize the efficacy against infection causing superbugs such as MRSA and Pseudomonas aeruginosa. JAC-Antimicrobial Resistance, 5(Supplement_1), dlac133-008. (Impact factor 2.9).
  3. Ismail, E. A., Devnarain, N., Govender, T., & Omolo, C. A. (2022). Stimuli-responsive and biomimetic delivery systems for sepsis and related complications. Journal of Controlled Release, 352, 1048-1070, (Impact factor 11.467).
  4. Musiba, G.N, Sangeda, R.Z, Omolo, C.A, Minzi M, Bwire, G, Ruggajo, P, Kingo, M.R , Maseru, L. (2022). Bacterial profile and Antibiogram for Hemodialysis Patients at Muhimbili National Hospital, Tanzania: A cross-sectional study. Pharmaceutical Journal of Kenya, (Just accepted)
  5. Elhassan, E., Devnarain, N., Mohammed, M., Govender, T., & Omolo, C. A. (2022). Engineering hybrid nanosystems for efficient and targeted delivery against bacterial infections. Journal of Controlled Release, 351, 598-622. (Impact factor 11.467).
  6. Makhathini, S. S., Omolo, C. A., Kiruri, L. W., Walvekar, P., Devnarain, N., Mocktar, C., & Govender, T. (2022). Synthesis of pH-responsive Dimethylglycine Surface-modified Branched Lipids for Targeted Delivery of Antibiotics. Chemistry and Physics of Lipids, 105241. (Impact factor 3.57)
  7. Ibrahim, U. H., Devnarain, N., Mohammed, M., Omolo, C. A., Gafar, M. A., Salih, M., … & Govender, T. (2022). Dual acting acid-cleavable self-assembling prodrug from hyaluronic acid and ciprofloxacin: A potential system for simultaneously targeting bacterial infections and cancer. International Journal of Biological Macromolecules. (Impact factor 8.025).
  8. Nwabuife, J. C., Omolo, C. A., & Govender, T. (2022). Nano delivery systems to the rescue of ciprofloxacin against resistant bacteria “E. coli; P. aeruginosa; Saureus; and MRSA” and their infections. Journal of Controlled Release, 349, 338-353., (Impact factor 11.467)
  9. Fasiku, V. O., Omolo, C. A., Kiruri, L. W., Devnarain, N., Faya, M., Mocktar, C., & Govender, T. (2022). A hyaluronic acid-based nanogel for the co-delivery of nitric oxide (NO) and a novel antimicrobial peptide (AMP) against bacterial biofilms. International Journal of Biological Macromolecules. 206, 381-397. (Impact factor 8.025).
  10. Sayyad N, Maji R, Omolo C.A, Majeed AG, Ibrahim Us, Pathan TK, Devnarain N, Karpoormath R, Dhawan S, Obakachi VA, Merugu SR, Kayamba F, Mahlalela M, Govender T, Tzakos AG, Singh S (2021). Development of niosomes for encapsulating captopril-quercetin prodrug to combat hypertension, International Journal of Pharmaceutics, 609, 121191 (Impact factor 6.510).
  11. Osman N, Devnarain N, Omolo C.A., Fasiku V, Jaglal Y, Govender T. (2021). Surface modification of nano-drug delivery systems for enhancing targeted delivery of anti-bacterial. WIREs Nanomedicine & Nanobiotechnology 14, 14, e1758 (Impact Factor 9.423) (Just accepted) https://doi.org/10.1002/wnan.1758.
  12. Omolo C.A., Hassan D., Devnarain N, Jaglal Y, Mocktar C, Kalhapure, R. S., Jadhav, M, Govender T. (2021). Formulation of pH responsive multilamellar vesicles for targeted delivery of hydrophilic antibiotics. Colloids And Surfaces B-Biointerfaces, 207, 112043 (Impact Factor 5.999).
  13. Maji R, Omolo C.A, Jaglal Y, Singh S, Devnarain N, Mocktar C, Govender T. (2021). A transferosome-loaded bigel for enhanced transdermal delivery and antibacterial activity of vancomycin hydrochloride. International Journal of Pharmaceutics,607, 120990 (Impact factor 6.510)..
  14. Ibrahima U.H, Devnarain N, Omolo C.A, Mocktar C, Govender T. (2021). Biomimetic pH/ lipase dual responsive vitamin-based solid lipid nanoparticles for on-demand delivery of vancomycin. International Journal of Pharmaceutics, 607, 120960 (Impact factor 6.510).
  15. Fasiku V, Omolo C.A, Devnarain N, Ibrahim U.H, Rambharose S, Mbuso F, Mocktar C, Singh S, Govender T. (2021). A chitosan-based hydrogel for the dual delivery of antimicrobial agents against a bacterial MRSA biofilm infected wound. ACS Omega, 6, 34, 21994–22010 (Impact factor 4.132).
  16. Jaglal Y, Osman N, Omolo C.A., Devnarain N, Mocktar C, Govender T. (2021). Formulation of pH-responsive lipid-polymer hybrid nanoparticles for co-delivery and enhancement of the antibacterial activity of vancomycin and 18β-glycyrrhetinic acid. Journal of Drug Delivery Science and Technology, 64, 102607 (Impact Factor 5.062).
  17. Oyima J, Omolo C.A., Amuhaya E.K. (2021). Photodynamic Antimicrobial Chemotherapy: Advancements in Porphyrin-Based Photosensitizer Development. Frontiers in Chemistry, 9, 635344. (Impact Factor 5.221).
  18. Hassan D., Omolo C.A., Fasiku V.O., Ahmed E. Mocktar C., Nkambule B., Govender T. (2020). Formulation of pH-responsive Quatsomes from Quaternary Bicephalic Surfactant and Cholesterol for Enhanced Activity of Antibiotics against Methicillin-Resistant Staphylococcus aureus. Pharmaceutics, 12.11, 1093. (Impact factor 6.525).
  19. Omolo, C. A, Megrab, N. A., Kalhapure, R. S., Agrawal, N, Jadhav, M, Mocktar, C, Rambharose.S, Maduray, K, Nkambule. B, Govender. T. (2021). Liposomes with pH Responsive “On and Off” Switches for Targeted and Intracellular Delivery of Antibiotics. Journal of Liposome Research, 31(1), 45-63. (Impact Factor 3.648.)
  20. Mbuso F., Omolo, C. A., Maji R., Walwaker P., Mocktar, C., Nkambule. B., Albericio F., De la Torre B.G., & Govender, T. (2020). Novel formulation of antimicrobial peptides enhances antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA). Amino Acids 52, 1439 – 1457 (Impact factor 3.520).
  21. Omolo C.A., Nikki Soni, Fasiku V.O, C., Makhraj. I., Govender. T. (2020) Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus, European Journal of Pharmacology, 883(15) 173348 (Impact factor 5.195).
  22. Salih,M., Omolo C.A., Fasiku V.O., Devnarain, Ahmed E., Mocktar C., Govender T. (2020). Supramolecular Self-Assembled Drug Delivery System (SADDs) of Vancomycin and Tocopherol Succinate as an Antibacterial Agent: In vitro, In silico and In vivo Evaluations. Journal of Pharmaceutical Development and Technology, 25.9, 1090-1108. (Impact factor 3.133).
  23. Salih M, Walvekar P, Omolo C.A., Elrashedy A. A, Devnarain N, Waddad A.Y, Fasiku V, Mocktar C, Govender T. (2020). A Self-Assembled Polymer Therapeutic for Simultaneously Enhancing Solubility and Antimicrobial Activity and Lowering Serum Albumin Binding of Fusidic acid. Journal of Biomolecular Structure & Dynamics 39(17), 6567-6584 (Impact Factor 3.549)
  24. Fasiku V.O., Omolo C.A., Govender T. (2020). Free radical-releasing systems for targeting biofilms. Journal of Controlled Release, 290, 112–128. (Impact factor 11.467) 322(10) 248-273
  25. Makhathini, S., Omolo, C. A, Gannimani, R., Mocktar, C., Govender, T. (2020). pH-Responsive Micelles from Oleic Acid Tail and Propionic Acid Heads Dendritic Amphiphile for Delivery of Antibiotics. Journal of Pharmaceutical Sciences. 109. 8, 2594-2606 (impact factor 3.784).
  26. Salih,M , Omolo C.A, Agrawal, N, Walvekar P, Waddad, A. Y., Mocktar, C., Ramdhin C, Govender T(2020). Supramolecular Amphiphiles of Beta-Cyclodextrin and Oleyl Amine for enhancement of Vancomycin delivery. International Journal of Pharmaceutics,574, 118881(impact factor 6.510).
  27. Hassan, D., Omolo, C. A., Mocktar, C., & Govender, T. (2020). Nanoplexes molecular patterns for vancomycin efficacy against methicillin-resistance Staphylococcus aureus. Access Microbiology, 2(2), 2
  28. Hassan D., Omolo C.A., N., Fasiku V.O, Mocktar C., Govender T. (2019). Novel chitosan-based pH-responsive lipid-polymer hybrid nanovesicles (OLA-LPHVs) for delivery of vancomycin against methicillin-resistant Staphylococcus aureus infections. International Journal of Biological Macromolecules, 558,143–156. (Impact factor 8.025)
  29. Maji. R., Omolo. C.A., Agrawal. N., Maduray. K., Mokhtar. C., Makhraj. I., Govender. T. (2019) pH-responsive lipid-dendrimer hybrid nanoparticles: An approach to target and eliminate intracellular pathogens. Molecular Pharmaceutics, 16(11), 4594-4609. (Impact factor 5.364).
  30. Osman N., Omolo C.A, Gannimani R., Waddad A.Y., Rambharose S., Mocktara C., Singh S., Parboosing R., Govender T. (2019). Novel fatty acid-based pH-responsive nanostructured lipid carriers for enhancing antibacterial delivery. Journal of Drug Delivery Science and Technology, 53,101125. (Impact factor 5.062).
  31. Hassan D., Omolo C.A., Gannimani R., Waddad A.Y., Rambharose S.,Agrawal N., Mocktar C., Govender T. (2019). Delivery of novel vancomycin nanoplexes for combating Methicillin Resistant staphylococcus aureus (MRSA) infections. International Journal of Pharmaceutics, 558,143–156. (Impact factor 6.510)
  32. Makhathini, S. S, Kalhapure, R. S., Jadhav, M., Waddad, A. Y., Gannimani, R., Omolo, C. A, Rambharose, S., Mocktar, C., Govender, T. (2019). Novel two chain fatty acid based-lipids for development of vancomycin pH-responsive liposomes against Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus (MRSA). Journal of Drug Targeting Journal of Drug Targeting. 27(10), 1094-1107. (Impact Factor 5.121)
  33. Mbuso F., Kalhapure, R. S., Agrawal, N., Dhumal D., Omolo C.A., Akamanchi K.G., and Govender T. (2018), Antimicrobial cell penetrating peptides (aCPPs) with bacterial cell specificity: Pharmacophore modelling, QSAR and Molecular Dynamics. Journal of Biomolecular Structure and Dynamics, 1, 1-10. (Impact factor 3.549)
  34. Mhule D., Kalhapure, R. S., Jadhav, M., Omolo, C. A., Rambharose, S., Waddad, A. Y., Mocktar, C., & Govender, T. (2018). Synthesis of an oleic acid-based pH-responsive lipid and its application in nanodelivery of vancomycin. International Journal of Pharmaceutics, 550(1-2), 149-159. (Impact factor 6.510)
  35. Faya, M., Kalhapure, R. S., Kumalo, H. M., Waddad, A. Y., Omolo, C., & Govender, T. (2017). Conjugates and nano-delivery of antimicrobial peptides for enhancing therapeutic activity. Journal of Drug Delivery Science and Technology, 44, 153-171. (Impact factor 5.062)
  36. Omolo, C. A., Kalhapure, R. S., Agrawal, N., Jadhav, M, Rambharose, S., Mocktar, C., & Govender, T. (2018). A Hybrid of mPEG-b-PCL and G1-PEA Dendrimer for Enhancing Nano Delivery of Antibiotics. Journal of Controlled Release, 290, 112–128. (Impact factor 11.467)
  37. Omolo, C. A., Kalhapure, R. S., Agrawal, N., Rambharose, S., Mocktar, C., & Govender, T. (2018). Formulation and Molecular Dynamics Simulations of a Fusidic Acid Nanosuspension for Simultaneously Enhancing Solubility and Antibacterial Activity. Molecular Pharmaceutics, 15(8), 3512-3526. (Impact factor 5.364).
  38. Omolo, C. A., Kalhapure, R. S., Jadhav, M., Rambharose, S., Mocktar, C., Ndesendo, V. M., & Govender, T. (2017). Pegylated oleic acid: A promising amphiphilic polymer for nano-antibiotic delivery. European Journal of Pharmaceutics and Biopharmaceutics, 112, 96-108. (Impact factor 5.589).

Book Chapters:

  1. Gill, A., Zondi, N., Chauhan, R., Faya, M., Karpoormath, R., Omolo, C. A., (2022). Nanobioengineering: A promising approach for early detection of COVID-19. Hussain, G. M., and Shukla, S. K., in Sensing tools and techniques for covid-19: Developments and Challenges in Analysis and Detection of Coronavirus. Elsevier Pages. 151-193.
  2. Ismail, E. A., Faya, M., Amuhaya, E., Omolo, C. A., & Govender, T. (2022). Biodegradable Polymers: Synthesis to Advanced Biomedical Applications. Gupta R.K, In Conducting Polymers CRC Press Pages. 81-100.
  3. Fasiku, V., Amuhaya, E. K., Rajab, K. M., & Omolo, C. A. (2021). Nano and Microparticles Encapsulation Via Covalent Drug Conjugation. Nedal Abu-Thabit, in Nano-and Microencapsulation: Techniques and Applications, IntechOpen Pages 137 -168.
  4. Oyima J, Omolo C.A., Amuhaya E.K. (2021). Photodynamic Antimicrobial Chemotherapy: Advancements in Porphyrin-Based Photosensitizer Development. Nyokong T, Amine A, Balogun E.O, Mishra S and Ebenso E.E, Rising Stars: Africa, Frontiers in Chemistry Pages 117 -131
  5. Omolo CA, Kalhpaure RS, Sikwal DR, Govender T (2020). Amphiphilic Dendrimers for Drug Delivery in Torchillin, V (Ed), Handbook of Materials for Nanomedicine: Polymeric Nanomaterials 1, 54. Jenny Stanford Publishing, Pages 159-205.

Article submitted and under review:

  1. Mohammed M, Ibrahim, U. H, Aljoundic A, Omolo C.A, Devnarain N, Gafar M.A, Govender T. (2023). Enzyme-responsive biomimetic solid lipid nanoparticles for antibiotic delivery against hyaluronidase-secreting bacteria. International Journal of Pharmaceutics. (Impact factor 6.510) (Under review manuscript IJPHARM-D-22-03025R1). (Collaboration research).
  2. Omolo C.A, Fasiku V.O, Nwabuife J.C, Amuhaya E.K, Mohamed M, Kalhapure K, Govender. T. (2023). Surface Modification of Dendrimers for Targeting and Efficient Drug Delivery. Journal of Controlled Release, (under review), (Impact factor 11.467) (Lead Author/Co-Senior author).
  3. Mbwasi R, Omolo C.A, Ombaka E, Wiedenmayer K. (2023), Retrospective Antimicrobial Consumption Surveillance at Health Facility Level in Dodoma Region, Tanzania. PLOS One, (Impact factor 3.240) (Under review). (Collaboration research).
  4. Osman N, Omolo C.A, Devnarain N, Mocktar C, Rambharose S, Ibrahim U.H, Fasiku V.O, & Govender, T. (2023). Niosomes modified with a novel pH-responsive coating (mPEG-OA) enhance the antibacterial and anti-biofilm activity of vancomycin against methicillin-resistant Staphylococcus aureus. Journal of Drug Targeting Journal of Drug Targeting. (Impact factor 5.062), (Under review manuscript ID JDDST-D-22-00202). (Senior Co-Author/Postgrad Supervisor).
  5. Osman N, Mohammed M, Omolo C.A, Mocktar C, Rambharose S, Devnarain N, Gafar MA, Kiruri LW, Nwabuife J, Singh SD & Govender, T. (2023). Hyaluronidase inhibitor surface-modified niosomes: An efficient strategy for antibacterial and anti-biofilm drug delivery. International Journal of Pharmaceutics. (Impact factor 6.510) (Under review manuscript ID IJPHARM-D-22-00263). (Senior Co-Author/Postgrad Supervisor).

Selected Conference Presentations:

  1. Ibrahim U.H, Devnarain N, Omolo C.A, Govender T, Dual acting acid-cleavable self-assembling pro-drug from hyaluronic acid and ciprofloxacin: a potential biomimetic system for simultaneously targeting bacterial infections and cancer. Biological and Medicinal symposium, March 6-8, 2023 in Bonn, Germany.
  2. Ibrahim U.H, Devnarain N, Omolo C.A, Govender T, Dual acting acid-cleavable self-assembling pro-drug from hyaluronic acid and ciprofloxacin: a potential biomimetic system for simultaneously targeting bacterial infections and cancer. 42nd PSK Annual Scientific conference themed disruptive advances in Pharmacy for improved healthcare, June 1-5, 2022 in Mombasa, Kenya.
  3. Salih M, Omolo C.A, Agrawal N, Walvekar P, Waddad A.Y, Mocktar C, Govender T, Supramolecular Amphiphile of Beta-Cyclodextrin and Oleyl amine for enhancement of vancomycin delivery. AAPS PharmSci 360, November 3-6, 2019 in San Antonio, Texas, USA.
  4. Omolo C.A, Kalhapure R.S, Rambharose S, Mocktar C, Govender T, A novel six-armed PEG-b-PCL copolymer (6m-PEPEA) based on G1-PETIM dendrimer for nano delivery of vancomycin. The AAPS Annual Meeting and Exposition October 2, 2017, San Diego, USA.
  5. Omolo C.A, Rahul S. Kalhapure, Mahantesh Jadhav, Sanjeev Rambharose, Chunderika Mocktar, Thirumala Govender, A novel six-armed PEG-b-PCL copolymer based on G1 PETIM dendrimer for nano delivery of vancomycin. International Conference on Nanomedicine and Nanobiotechnology, September 25, 2017, Barcelona, Spain.
  6. Omolo C.A, Rahul S Kalhapure, Chunderika Mocktar, and Thirumala Govender, Polymeric micelles from PEGylated oleic acid for nano delivery of vancomycin. 4th African Pharma Congress June 20-21, 2016, Cape Town, South Africa.
  7. Daniel Hassan, Omolo C.A, Ayman Y. Waddad, Ramesh Gannimani, Sanjeev Rambharose, Chunderika Mocktar, Thirumala Govender. Novel delivery of vancomycin nanoplexes for targeting and combating of methicillin resistant staphylococcus aureus (MRSA) infections. Poster session presented at ASM Microbe June 7-11, 2018, Atlanta Georgia, USA.
  8. Omolo C.A, Kalhapure, R. S., Agrawal, N., Rambharose, S., Mocktar, C., & Govender, T. (2018). Formulation and Molecular Dynamics Simulations of a Fusidic Acid Nanosuspension for Simultaneously Enhancing Solubility and Antibacterial activity. Applied Nanotechnology and Nanoscience International conference. October 22-24 Berlin Germany.
  9. Daniel Hassan, Omolo C.A, Chunderika Mocktar, Thirumala Govender, Novel pH-responsive zwitterionic vancomycin-chitosan nanovesicles: In vitro Antimicrobial activity against Staphylococcus aureus (SA) and Methicillin-resistance Staphylococcus aureus (MRSA). APSA Annual Conference, 2-5 December 2018, Adelaide, Australia.
  10. Daniel Hassan, Omolo C.A, Chunderika Mocktar, Thirumala Govender, Novel Delivery of pH-responsive Vancomycin Nanovesicles against Superbug (MRSA) Infections. ASM Annual Meeting and Exposition, 20-24 June 2019, San Francisco, CA, USA.
  11. Daniel Hassan, Omolo C.A, Chunderika Mocktar, Thirumala Govender, Quaternary two-arm pH-responsive quatsomes for delivery and enhancement of Vancomycin activity against Methicillin-resistant Staphylococcus Aureus. CRC Annual Meeting and Exposition, 21-24 June 2019, Valencia, Spain.